Market Tracker

10/22 5:16pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

128.77
Data as of 4:01pm ET
 -1.61 / -1.23%
Today’s Change
102.60
Today|||52-Week Range
153.10
+9.68%
Year-to-Date

Today’s Trading

Previous close130.38
Today’s open128.43
Day’s range128.22 - 131.07
Volume1,928,610
Average volume (3 months)2,878,886
Market cap$43.5B
Dividend yield--
Data as of 4:01pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+31.43%
Earnings growth (next 5 years)+33.90%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book8.48

Competitors

 Today’s
change
Today’s
% change
SHPGShire PLC-1.01-0.54%
ALXNAlexion Pharmaceutic...-1.20-0.69%
AGNAllergan Inc-3.35-1.80%
VRTXVertex Pharmaceutica...-1.99-1.84%
Data as of 4:00pm ET, 10/22/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)$2.46
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts